[go: up one dir, main page]

NO20055616L - Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentet - Google Patents

Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentet

Info

Publication number
NO20055616L
NO20055616L NO20055616A NO20055616A NO20055616L NO 20055616 L NO20055616 L NO 20055616L NO 20055616 A NO20055616 A NO 20055616A NO 20055616 A NO20055616 A NO 20055616A NO 20055616 L NO20055616 L NO 20055616L
Authority
NO
Norway
Prior art keywords
drug
agent
antimicrobial
formulation
against organisms
Prior art date
Application number
NO20055616A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055616D0 (no
Inventor
James E Kipp
Joseph Chung Tak Wong
Mark J Doty
Christine L Rebbeck
Chong-Son Sun
Pavlos Papadopoulos
Barrett E Rabinow
Randy White
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of NO20055616D0 publication Critical patent/NO20055616D0/no
Publication of NO20055616L publication Critical patent/NO20055616L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20055616A 2003-04-29 2005-11-28 Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentet NO20055616L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46635403P 2003-04-29 2003-04-29
PCT/US2004/013268 WO2004096180A1 (fr) 2003-04-29 2004-04-29 Formulation destinee a rendre un medicament antimicrobien efficace contre des organismes normalement consideres comme etant resistant a ce medicament

Publications (2)

Publication Number Publication Date
NO20055616D0 NO20055616D0 (no) 2005-11-28
NO20055616L true NO20055616L (no) 2006-01-25

Family

ID=33418369

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055616A NO20055616L (no) 2003-04-29 2005-11-28 Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentet

Country Status (11)

Country Link
EP (1) EP1617818A1 (fr)
JP (1) JP2006525345A (fr)
KR (1) KR20060015553A (fr)
CN (1) CN1794975A (fr)
AU (1) AU2004234003A1 (fr)
BR (1) BRPI0409929A (fr)
CA (1) CA2523151A1 (fr)
MX (1) MXPA05011607A (fr)
NO (1) NO20055616L (fr)
WO (1) WO2004096180A1 (fr)
ZA (1) ZA200508467B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100858508B1 (ko) 2005-12-23 2008-09-12 주식회사 삼양사 아졸계 항진균제를 포함하는 조성물 및 그의 제조방법
EP2040675A1 (fr) * 2006-05-30 2009-04-01 Elan Pharma International Limited Formulations de posaconazole nanoparticulaire
FR2922107B1 (fr) * 2007-10-10 2010-02-26 Aventis Pharma Sa Nouvelles compositions a base de taxoides
US20090238867A1 (en) * 2007-12-13 2009-09-24 Scott Jenkins Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
EP2722053B1 (fr) * 2010-12-30 2017-10-25 Aktsionernoye Obshchestvo "Nauchnyi Tsentr Protivoinfektsionnyh Preparatov" Agent antibactérien destiné à traiter les maladies infectieuses d'origine bactérienne
CN102085176A (zh) * 2010-12-31 2011-06-08 江苏中丹制药有限公司 一种纳米级伊曲康唑外用制剂、其制备方法及其用途
CN102106832A (zh) * 2011-02-12 2011-06-29 华中师范大学 酮康唑纳米混悬剂冻干粉及其制备方法
WO2017007957A1 (fr) * 2015-07-07 2017-01-12 Mast Therapeutics, Inc. Formulations de poloxamère-188 à teneur en sodium réduite et procédés d'utilisation
CN111658601A (zh) * 2020-06-12 2020-09-15 浙江普利药业有限公司 伏立康唑外用制剂及其制备方法
IT202000030443A1 (it) * 2020-12-10 2022-06-10 Zambon Spa Polvere inalabile comprendente voriconazolo in forma cristallina
WO2025023975A1 (fr) * 2023-07-27 2025-01-30 Bard Peripheral Vascular, Inc. Procédés de préparation de supports bicouches phospholipidiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1245955C (zh) * 1998-05-29 2006-03-22 斯凯伊药品加拿大公司 热保护微粒组合物及其最终蒸汽灭菌的方法
JP2003509453A (ja) * 1999-09-21 2003-03-11 アールティーピー・ファーマ・インコーポレーテッド 生物学的に活性な物質の、表面改質された粒状組成物
BR0116377A (pt) * 2000-12-22 2005-12-13 Baxter Int Métodos para preparar partìculas submicronicamente dimensionadas de um composto orgânico, e para preparar uma suspensão de um composto farmaceuticamente ativo, e, composição de matéria
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix

Also Published As

Publication number Publication date
CN1794975A (zh) 2006-06-28
MXPA05011607A (es) 2005-12-15
NO20055616D0 (no) 2005-11-28
KR20060015553A (ko) 2006-02-17
BRPI0409929A (pt) 2006-04-25
AU2004234003A1 (en) 2004-11-11
ZA200508467B (en) 2006-09-27
EP1617818A1 (fr) 2006-01-25
CA2523151A1 (fr) 2004-11-11
JP2006525345A (ja) 2006-11-09
WO2004096180A1 (fr) 2004-11-11

Similar Documents

Publication Publication Date Title
NO20055616L (no) Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentet
NO20073559L (no) Nanopartiklulaere tacrolimus-formuleringer
TN2009000210A1 (en) Liquid formulation of carboxamide arthropodicides
IL145767A0 (en) Microbicidal formulation comprising an essential oil or their derivatives
WO2003045344A3 (fr) Compositions de dentifrice comprenant une phase stable faible en eau composee de polyphosphate et d'elements ioniques actifs
WO2005002542A3 (fr) Formulations de meloxicane nanoparticulaires
CA2326756A1 (fr) Compositions pharmaceutiques contenant des composes ameliorant l'absorption des principes actifs
CA2351386A1 (fr) Compositions aqueuses a base de glyphosate en forte concentration
WO2007041156A3 (fr) Formulations d'antibiotiques, doses posologiques, necessaires, et procedes
DE502005006879D1 (de) Wasserbasis
PL1713446T3 (pl) Nielamelarne trójskładnikowe kompozycje lipidów
ATE399847T1 (de) Reinigungsmittel vom typ der multiplen emulsion
BR0317554B1 (pt) Compostos peroxigenados revestidos com liberação controlada, um processo para preparação deles e uso dos mesmos
DE602006016125D1 (de) Dispergiermittel und zusammensetzungen davon
IL188092A0 (en) Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
EP1483965A4 (fr) Procede et agent de lutte contre les insectes nuisibles
JP2011520796A (ja) マイクロエマルション殺菌組成物
DK1307445T3 (da) Benzofuranderivater og deres anvendelse som antibakterielle midler
MY152837A (en) Disinfectant and/or bactericidal aqueous compositions
DE50210284D1 (de) Bioregulatorische wirkstoffkombination
GB0100643D0 (en) Liquid antimicrobial compositions
HUP0301864A2 (hu) Fenoláttartalmú, alacsony fagyáspontú készítmény
AU2003286210A1 (en) Smoke composition
WO2023111008A3 (fr) Composition aqueuse parfumée comprenant au moins deux tensioactifs, au moins une substance parfumante et au moins un diol
NO20012373D0 (no) Spröyteblanding inneholdende amfoterisk materiale for å redusere vonde lukter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application